251 related articles for article (PubMed ID: 8561968)
1. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
[TBL] [Abstract][Full Text] [Related]
2. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey.
Farfel GM; Kleven MS; Woolverton WL; Seiden LS; Perry BD
Brain Res; 1992 Apr; 578(1-2):235-43. PubMed ID: 1380862
[TBL] [Abstract][Full Text] [Related]
3. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
4. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
Thomas WS; Neal-Beliveau BS; Joyce JN
Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
[TBL] [Abstract][Full Text] [Related]
5. Prenatal cocaine exposure affects postnatal dopaminergic systems in various regions of the rat brain.
Choi SJ; Mazzio E; Kolta MG; Soliman KF
Ann N Y Acad Sci; 1998 May; 844():293-302. PubMed ID: 9668686
[TBL] [Abstract][Full Text] [Related]
6. Tyr-MIF-1 attenuates development of tolerance to spiperone-induced catalepsy in rats.
Kostrzewa RM; Kastin AJ
Brain Res Bull; 1993; 31(6):707-12. PubMed ID: 8100182
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
Cyr M; Morissette M; Barden N; Beaulieu S; Rochford J; Di Paolo T
Neuroscience; 2001; 102(1):151-8. PubMed ID: 11226678
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
Neisewander JL; Lucki I; McGonigle P
Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
[TBL] [Abstract][Full Text] [Related]
9. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
10. Regional differences in rat brain dopamine transporter binding: function of time after chronic cocaine.
Hitri A; Wyatt RJ
Clin Neuropharmacol; 1993 Dec; 16(6):525-39. PubMed ID: 9377588
[TBL] [Abstract][Full Text] [Related]
11. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.
Flores G; Wood GK; Liang JJ; Quirion R; Srivastava LK
J Neurosci; 1996 Nov; 16(22):7366-75. PubMed ID: 8929443
[TBL] [Abstract][Full Text] [Related]
12. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
13. Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum.
Mayfield RD; Larson G; Zahniser NR
Brain Res; 1992 Feb; 573(2):331-5. PubMed ID: 1387030
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice.
Womer DE; Jones BC; Erwin VG
Pharmacol Biochem Behav; 1994 Jun; 48(2):327-35. PubMed ID: 8090798
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
Wilson JM; Nobrega JN; Carroll ME; Niznik HB; Shannak K; Lac ST; Pristupa ZB; Dixon LM; Kish SJ
J Neurosci; 1994 May; 14(5 Pt 2):2966-79. PubMed ID: 8182452
[TBL] [Abstract][Full Text] [Related]
16. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.
Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A
Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392
[TBL] [Abstract][Full Text] [Related]
17. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.
Hooks MS; Juncos JL; Justice JB; Meiergerd SM; Povlock SL; Schenk JO; Kalivas PW
J Neurosci; 1994 Oct; 14(10):6144-52. PubMed ID: 7931568
[TBL] [Abstract][Full Text] [Related]
18. Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.
Rothman RB; Grieg N; Kim A; De Costa BR; Rice KC; Carroll FI; Pert A
Pharmacol Biochem Behav; 1992 Dec; 43(4):1135-42. PubMed ID: 1475296
[TBL] [Abstract][Full Text] [Related]
19. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
Pokora MJ; Richfield EK; Cory-Slechta DA
J Neurochem; 1996 Oct; 67(4):1540-50. PubMed ID: 8858938
[TBL] [Abstract][Full Text] [Related]
20. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.
Izenwasser S; Acri JB; Kunko PM; Shippenberg T
Synapse; 1998 Nov; 30(3):275-83. PubMed ID: 9776131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
